LeafNLP Demos
Back to explore

Report #2887122

Received Feb 27, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
ME
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (4)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (ENGERIX-B)GLAXOSMITHKLINE BIOLOGICALSUNK——
HEPAHEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Product storage error

Symptom narrative

potential administration after below temperature excursion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis, HBV (Engerix B) for prophylaxis and Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Havrix, Boostrix, Engerix B and Shingrix. On an unknown date, an unknown time after receiving Havrix, Boostrix, Engerix B and Shingrix, the patient experienced incorrect storage of drug (Verbatim: potential administration after below temperature excursion). The outcome of the incorrect storage of drug was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 19-FEB-2026 The batch number was not provided, and we are unable to contact the reporter.

Lab data

Test Name: temperature; Result Unstructured Data: (Test Result:4.5 celsius,Unit:unknown,Normal Low:,Normal High:) for 8 hours